A senior figure from a major global company has been appointed to lead the national and international programme to commemorate the voyage of the Pilgrim Fathers to the New World.
Charles Hackett, who is vice president of medicines commercialisation for pharmaceutical giant GlaxoSmithKline, has been selected to be at the helm of Mayflower400 in the UK.
